Lineage Cell Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $1.57 on 06/16/23, while the lowest value for the same period was recorded at $0.84 on 02/01/24.
52-week price history of LCTX Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Lineage Cell Therapeutics Inc’s current trading price is -12.04% away from its 52-week high, while its distance from the 52-week low is 64.02%. The stock’s price range during the 52-week period has remained between $0.84 and $1.57. In the Healthcare sector, the company’s shares saw a trading volume of around 1.31 million for the day, which was evidently higher than the average daily volume of 0.81 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Lineage Cell Therapeutics Inc (LCTX) has experienced a quarterly rise of 35.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 260.12M and boasts a workforce of 75 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0768, with a change in price of -0.0150. Similarly, Lineage Cell Therapeutics Inc recorded 659,323 in trading volume during the last 100 days, posting a change of -1.16%.
Examining LCTX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LCTX stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.03.
LCTX Stock Stochastic Average
As of today, Lineage Cell Therapeutics Inc’s raw stochastic average for the last 50 days stands at 92.53%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 91.67%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 78.70% and 68.96%, respectively.
LCTX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 26.61%. However, over the past six months, we’ve seen a weaker performance of 0.01%. The price of LCTX fallen by 31.44% over the last 30 days. And in the last five days, it has surged by 24.33%.
